The international quotidian hemodialysis registry: Rationale and challenges

Hemodialysis International

Volumn 12, Issue SUPPL. 1, 2008, Pages

  Lindsay, Robert M ^a   Carter, Shannon ^a   Awaraji, Christian ^b   Suri, Rita S ^a   Nesrallah, Gihad ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Medix Technologies Incorporated   (Canada)

^c HUMBER RIVER REGIONAL HOSPITAL   (Canada)

Author keywords

Alternative regimes; Daily; Hemodialysis; Nocturnal; Registry

Indexed keywords

ARTICLE; CLINICAL PRACTICE; ELECTRONIC MEDICAL RECORD; FINANCIAL MANAGEMENT; HEALTH CARE UTILIZATION; HEMODIALYSIS; HOME DIALYSIS; INFORMATION PROCESSING; INTERNATIONAL QUOTIDIAN HEMODIALYSIS REGISTRY; MEDICAL RESEARCH; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; REGISTER; TREATMENT DURATION;

HEMODIALYSIS, HOME; HUMANS; INTERNATIONAL COOPERATION; KIDNEY FAILURE, CHRONIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES;

EID: 47649089507     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00299.x     Document Type: Article

References (24)

1. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002; 347: 2010-2019.
2. Rao M, Muirhead N, Klarenbach S, Moist L, Lindsay RM. Management of anemia with quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl 1): 18-23.
3. Pierratos A. Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant. 1999; 14: 2835-2840.
4. Fagugli RM, Reboldi G, Quintaliani G, et al. Short-daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001; 38: 371-376.
5. Chan C, Harvey PJ, Pierratos A, Miller JA, Floras JS. Short-term blood pressure, noradrenergic and vascular effects of nocturnal hemodialysis. Hypertension 2003; 42: 925-931.
6. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl): 13-17.
7. Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int. 1999; 55: 2467-2476.
8. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int. 1998; 53: 1399-1404.
9. Lindsay RM, Alhejaili F, Nesrallah G, et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl): 24-29.
10. Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A. Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol. 2002; 13: 265-268.
11. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002; 61: 2235-2239.
12. Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis. 2003; 42 (Suppl): 30-35.
13. McPhatter LL, Lockridge RSJ, Albert J, et al. Nightly home hemodialysis: Improvement in nutrition and quality of life. Adv Ren Replace Ther. 1999; 6: 358-365.
14. Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G. The case for daily dialysis: Its impact on costs and quality of life. Am J Kidney Dis. 2001; 37: 777-789.
15. Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis. 2003; 42 (Suppl): 36-41.
16. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int. 2003; 64: 1004-1011.
17. Brissenden JE, Pierratos A, Ouwendyk M, Roscoe JM. Improvements in quality of life with nocturnal hemodialysis (abstract). J Am Soc Nephrol. 1998; 9: 168A.
18. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003; 42: 1020-1035.
19. NIH. Frequent Hemodialysis Clinical Trials, 2003. Available from: http://grants1.nih.gov/grants/guide/rfa-files/RFA-DK-03-005.html.
20. Suri RS, Garg AX, Chertkow GM, et al. Frequent Hemodialysis Network (FHN) randomized trials: Study design. Kidney Int. 2007; 71: 349-359.
21. Kliger AS. Frequent Hemodialysis Network Study Group. High-frequency hemodialysis: Rationale for randomized clinical trials. Clin J Am Soc Nephrol. 2007; 2: 390-392.
22. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect." J Clin Epidemiol. 2001; 54: 217-224.
23. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987; 40: 373-383.
24. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis. 2003; 42: 125-132.